List of works - Lawrence Soon-U Lee

(3R, 9R, 10R)-Panaxytriol: A molecular-based nutraceutical with possible application to cancer prevention and treatment.

scientific article published on December 2008

1-year pulmonary function and health status in survivors of severe acute respiratory syndrome

scientific article published in September 2005

A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERα protein ⬇️

scientific article published on February 16, 2012

Accelerator mass spectrometry measurement of intracellular concentrations of active drug metabolites in human target cells in vivo

scientific article published on October 27, 2010

Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.

scientific article published in February 2009

Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial

scientific article

Darunavir/ritonavir and efavirenz exert differential effects on MRP1 transporter expression and function in healthy volunteers.

scientific article published in January 2010

Differential effects of tipranavir plus ritonavir on atorvastatin or rosuvastatin pharmacokinetics in healthy volunteers.

scientific article published on 10 August 2009

Dynamics of progestogenic activity in serum following administration of Ligusticum chuanxiong

scientific article published on 15 April 2006

Hypocortisolism in survivors of severe acute respiratory syndrome (SARS).

scientific article published in August 2005

Interactions between natural health products and antiretroviral drugs: pharmacokinetic and pharmacodynamic effects

scientific article published on 08 September 2006

Pharmacokinetics of darunavir at 900 milligrams and ritonavir at 100 milligrams once daily when coadministered with efavirenz at 600 milligrams once daily in healthy volunteers

scientific article

Pharmacokinetics of indinavir at 800, 600, and 400 milligrams administered with ritonavir at 100 milligrams and efavirenz in ethnic chinese patients infected with human immunodeficiency virus.

scientific article

Possible differential induction of phase 2 enzyme and antioxidant pathways by american ginseng, Panax quinquefolius

scientific article published on 4 March 2008

Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome

scientific article published in September 2004

Quality of life and psychological status in survivors of severe acute respiratory syndrome at 3 months postdischarge

scientific article published in May 2006

List of works by Lawrence Soon-U Lee

(3R, 9R, 10R)-Panaxytriol: A molecular-based nutraceutical with possible application to cancer prevention and treatment.

1-year pulmonary function and health status in survivors of severe acute respiratory syndrome

A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERα protein ⬇️

Accelerator mass spectrometry measurement of intracellular concentrations of active drug metabolites in human target cells in vivo

Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.

Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial

Darunavir/ritonavir and efavirenz exert differential effects on MRP1 transporter expression and function in healthy volunteers.

Differential effects of tipranavir plus ritonavir on atorvastatin or rosuvastatin pharmacokinetics in healthy volunteers.

Dynamics of progestogenic activity in serum following administration of Ligusticum chuanxiong

Hypocortisolism in survivors of severe acute respiratory syndrome (SARS).

Interactions between natural health products and antiretroviral drugs: pharmacokinetic and pharmacodynamic effects

Pharmacokinetics of darunavir at 900 milligrams and ritonavir at 100 milligrams once daily when coadministered with efavirenz at 600 milligrams once daily in healthy volunteers

Pharmacokinetics of indinavir at 800, 600, and 400 milligrams administered with ritonavir at 100 milligrams and efavirenz in ethnic chinese patients infected with human immunodeficiency virus.

Possible differential induction of phase 2 enzyme and antioxidant pathways by american ginseng, Panax quinquefolius

Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome

Quality of life and psychological status in survivors of severe acute respiratory syndrome at 3 months postdischarge